AM
Therapeutic Areas
BioArctic Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lecanemab | Alzheimer's Disease | Launched |
| BAN2802 | Parkinson's Disease | Phase 1 |
| BAN2401 | Alzheimer's Disease | Preclinical |
| Stem Cell Program | ALS | Research |
Leadership Team at BioArctic
GO
Gunilla Osswald
CEO & President
EA
Emilie Ankarcrona Smith
General Counsel, Head of Legal & IP
OB
Oskar Bosson
VP, Head of IR & Communication
ES
Eugen Steiner
Chairman of the Board
CE
Cecilia Edström
Board Member
AE
Anna-Lena Engwall
Board Member
PG
Pär Gellerfors
Board Member, Co-Founder
LL
Lars Lannfelt
Board Member, Co-Founder